Literature DB >> 27815945

A transmission-virulence evolutionary trade-off explains attenuation of HIV-1 in Uganda.

François Blanquart1,2,3, Mary Kate Grabowski4,5, Joshua Herbeck6,7, Fred Nalugoda8, David Serwadda8,9, Michael A Eller10,11, Merlin L Robb10,11, Ronald Gray4,5,8, Godfrey Kigozi8, Oliver Laeyendecker12,13, Katrina A Lythgoe1,2,3,14, Gertrude Nakigozi8, Thomas C Quinn12,13, Steven J Reynolds12,13, Maria J Wawer4,5, Christophe Fraser1,2,3,15.   

Abstract

Evolutionary theory hypothesizes that intermediate virulence maximizes pathogen fitness as a result of a trade-off between virulence and transmission, but empirical evidence remains scarce. We bridge this gap using data from a large and long-standing HIV-1 prospective cohort, in Uganda. We use an epidemiological-evolutionary model parameterised with this data to derive evolutionary predictions based on analysis and detailed individual-based simulations. We robustly predict stabilising selection towards a low level of virulence, and rapid attenuation of the virus. Accordingly, set-point viral load, the most common measure of virulence, has declined in the last 20 years. Our model also predicts that subtype A is slowly outcompeting subtype D, with both subtypes becoming less virulent, as observed in the data. Reduction of set-point viral loads should have resulted in a 20% reduction in incidence, and a three years extension of untreated asymptomatic infection, increasing opportunities for timely treatment of infected individuals.

Entities:  

Keywords:  adaptation; epidemiology; evolutionary biology; genomics; global health; quantitative genetics; selection; transmission-virulence trade-off; viral evolution; virus

Mesh:

Year:  2016        PMID: 27815945      PMCID: PMC5115872          DOI: 10.7554/eLife.20492

Source DB:  PubMed          Journal:  Elife        ISSN: 2050-084X            Impact factor:   8.140


  63 in total

1.  A general theory for the evolutionary dynamics of virulence.

Authors:  Troy Day; Stephen R Proulx
Journal:  Am Nat       Date:  2004-04-02       Impact factor: 3.926

2.  Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control.

Authors:  Narcis B Kabatereine; Simon Brooker; Edridah M Tukahebwa; Francis Kazibwe; Ambrose W Onapa
Journal:  Trop Med Int Health       Date:  2004-03       Impact factor: 2.622

3.  HIV incidence and sexually transmitted disease prevalence associated with condom use: a population study in Rakai, Uganda.

Authors:  S Ahmed; T Lutalo; M Wawer; D Serwadda; N K Sewankambo; F Nalugoda; F Makumbi; F Wabwire-Mangen; N Kiwanuka; G Kigozi; M Kiddugavu; R Gray
Journal:  AIDS       Date:  2001-11-09       Impact factor: 4.177

4.  Evidence for positive epistasis in HIV-1.

Authors:  Sebastian Bonhoeffer; Colombe Chappey; Neil T Parkin; Jeanette M Whitcomb; Christos J Petropoulos
Journal:  Science       Date:  2004-11-26       Impact factor: 47.728

5.  Mortality associated with HIV infection in rural Rakai District, Uganda.

Authors:  N K Sewankambo; R H Gray; S Ahmad; D Serwadda; F Wabwire-Mangen; F Nalugoda; N Kiwanuka; T Lutalo; G Kigozi; C Li; M P Meehan; H Brahmbatt; M J Wawer
Journal:  AIDS       Date:  2000-10-20       Impact factor: 4.177

6.  Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.

Authors:  Michael Brown; Moses Kizza; Christine Watera; Maria A Quigley; Samantha Rowland; Peter Hughes; James A G Whitworth; Alison M Elliott
Journal:  J Infect Dis       Date:  2004-10-20       Impact factor: 5.226

7.  Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group.

Authors:  M J Wawer; N K Sewankambo; D Serwadda; T C Quinn; L A Paxton; N Kiwanuka; F Wabwire-Mangen; C Li; T Lutalo; F Nalugoda; C A Gaydos; L H Moulton; M O Meehan; S Ahmed; R H Gray
Journal:  Lancet       Date:  1999-02-13       Impact factor: 79.321

8.  Population-level HIV declines and behavioral risk avoidance in Uganda.

Authors:  Rand L Stoneburner; Daniel Low-Beer
Journal:  Science       Date:  2004-04-30       Impact factor: 47.728

9.  Does patient sex affect human immunodeficiency virus levels?

Authors:  Monica Gandhi; Peter Bacchetti; Paolo Miotti; Thomas C Quinn; Fulvia Veronese; Ruth M Greenblatt
Journal:  Clin Infect Dis       Date:  2002-07-02       Impact factor: 9.079

10.  Human immunodeficiency virus acquisition associated with genital ulcer disease and herpes simplex virus type 2 infection: a nested case-control study in Rakai, Uganda.

Authors:  David Serwadda; Ronald H Gray; Nelson K Sewankambo; Fred Wabwire-Mangen; Michael Z Chen; Thomas C Quinn; Tom Lutalo; Noah Kiwanuka; Godfrey Kigozi; Fred Nalugoda; Mary P Meehan; Rhoda Ashley Morrow; Maria J Wawer
Journal:  J Infect Dis       Date:  2003-10-28       Impact factor: 5.226

View more
  24 in total

Review 1.  Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.

Authors:  Santiago Avila-Rios; Jonathan M Carlson; Mina John; Simon Mallal; Zabrina L Brumme
Journal:  Curr Opin HIV AIDS       Date:  2019-05       Impact factor: 4.283

2.  HIV-1 Subtype Distribution and Diversity Over 18 Years in Rakai, Uganda.

Authors:  Susanna L Lamers; Rebecca Rose; Sissy Cross; Christopher W Rodriguez; Andrew D Redd; Thomas C Quinn; David Serwadda; Joseph Kagaayi; Godfrey Kigozi; Ronald Galiwango; Ronald H Gray; M Kate Grabowski; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2020-06       Impact factor: 2.205

3.  Recombination Analysis of Near Full-Length HIV-1 Sequences and the Identification of a Potential New Circulating Recombinant Form from Rakai, Uganda.

Authors:  Adam A Capoferri; Susanna L Lamers; Mary Kate Grabowski; Rebecca Rose; Maria J Wawer; David Serwadda; Ronald H Gray; Thomas C Quinn; Godfrey Kigozi; Joseph Kagaayi; Oliver Laeyendecker
Journal:  AIDS Res Hum Retroviruses       Date:  2020-03-02       Impact factor: 2.205

4.  Effect of the Latent Reservoir on the Evolution of HIV at the Within- and Between-Host Levels.

Authors:  Hilje M Doekes; Christophe Fraser; Katrina A Lythgoe
Journal:  PLoS Comput Biol       Date:  2017-01-19       Impact factor: 4.475

5.  Estimating the impact of antiretroviral treatment on adult mortality trends in South Africa: A mathematical modelling study.

Authors:  Leigh F Johnson; Margaret T May; Rob E Dorrington; Morna Cornell; Andrew Boulle; Matthias Egger; Mary-Ann Davies
Journal:  PLoS Med       Date:  2017-12-12       Impact factor: 11.069

6.  Viral genetic variation accounts for a third of variability in HIV-1 set-point viral load in Europe.

Authors:  François Blanquart; Chris Wymant; Marion Cornelissen; Astrid Gall; Margreet Bakker; Daniela Bezemer; Matthew Hall; Mariska Hillebregt; Swee Hoe Ong; Jan Albert; Norbert Bannert; Jacques Fellay; Katrien Fransen; Annabelle J Gourlay; M Kate Grabowski; Barbara Gunsenheimer-Bartmeyer; Huldrych F Günthard; Pia Kivelä; Roger Kouyos; Oliver Laeyendecker; Kirsi Liitsola; Laurence Meyer; Kholoud Porter; Matti Ristola; Ard van Sighem; Guido Vanham; Ben Berkhout; Paul Kellam; Peter Reiss; Christophe Fraser
Journal:  PLoS Biol       Date:  2017-06-12       Impact factor: 8.029

7.  Modelling the evolution of HIV-1 virulence in response to imperfect therapy and prophylaxis.

Authors:  David R M Smith; Nicole Mideo
Journal:  Evol Appl       Date:  2017-02-11       Impact factor: 5.183

8.  Effects of contact structure on the transient evolution of HIV virulence.

Authors:  Sang Woo Park; Benjamin M Bolker
Journal:  PLoS Comput Biol       Date:  2017-03-31       Impact factor: 4.475

9.  Evolution of HIV-1 within untreated individuals and at the population scale in Uganda.

Authors:  Jayna Raghwani; Andrew D Redd; Andrew F Longosz; Chieh-Hsi Wu; David Serwadda; Craig Martens; Joseph Kagaayi; Nelson Sewankambo; Stephen F Porcella; Mary K Grabowski; Thomas C Quinn; Michael A Eller; Leigh Anne Eller; Fred Wabwire-Mangen; Merlin L Robb; Christophe Fraser; Katrina A Lythgoe
Journal:  PLoS Pathog       Date:  2018-07-27       Impact factor: 6.823

10.  Transmission-clearance trade-offs indicate that dengue virulence evolution depends on epidemiological context.

Authors:  Rotem Ben-Shachar; Katia Koelle
Journal:  Nat Commun       Date:  2018-06-15       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.